We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Smith & Nephew Plc | LSE:SN. | London | Ordinary Share | GB0009223206 | ORD USD0.20 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
9.00 | 0.92% | 985.60 | 984.80 | 985.20 | 990.80 | 976.60 | 979.20 | 5,727,605 | 16:35:14 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Ortho,prosth,surg Appl,suply | 5.55B | 263M | 0.3011 | 32.71 | 8.6B |
Date | Subject | Author | Discuss |
---|---|---|---|
16/4/2007 10:45 | large volumes this morning , any news anywhere ?? | scrapman | |
30/3/2007 16:31 | Remains a buy with Citigroup and raises price target on back of Plus aquisition. | maiseymouse | |
19/3/2007 07:08 | big sell note out from goldman sachs. | maiseymouse | |
12/3/2007 09:23 | strong comments on the earnings front | scrapman | |
12/3/2007 07:10 | I think Dresdner Kleinwort see sonme upside from current levels and has upped its price target to 755p. I think there is some way to go for this one. The story is under-appreciated by the market. | maiseymouse | |
14/2/2007 13:16 | active this am showing very steady gains | scrapman | |
13/2/2007 12:11 | I think the market is dreaming if some private equity company is going to come around and buy this up. Here's a bunch from brokers - looks like up to 700p is possible UBS - move from Buy to Neutral 675p PT from 662p Bernstein - raising from 560p to 580p. Golden Sachs - up PT from 580p to 605 maintain Neutral Merrill Lyech -Raising price target to 690p retains Buy Casanova - Maintains In-Line | liquidkid | |
13/2/2007 12:10 | 1.5 bn buyback instituted. Hold on to your seats! | phillis | |
10/2/2007 01:01 | So let me get this right. UBS rate this as a BUY on 31st Jan with a target of 662p & then a mere 9 days later downgrade this to NEUTRAL with a target of 675p. | jackster | |
08/2/2007 15:04 | Glad I bought in yesterday. Usually it drops when I buy just before results. | jackster | |
08/2/2007 11:34 | Mega buyback of $1.5bn Also, like the sound of this Earnings Improvement Programme to focus on margin enhancement. Current Op margin of 20% is at the low end of industry. | liquidkid | |
08/2/2007 11:15 | Another stock I have is EMC which could fly today in the US | cat100 | |
08/2/2007 11:12 | Rocking now. Well done Kakie | cat100 | |
08/2/2007 11:08 | Well Katie wrong but right !!! | samenic | |
01/2/2007 21:45 | I heard today that Biomet (now owned by Goldman Sachs) are about to make a bid for Smith and Nephew!!!! Fill your Boots I bought shedloads today! Katie Price | katieprice | |
24/1/2007 12:48 | after recent pretty steady rises , any more comments that this is now a target | scrapman | |
18/1/2007 12:16 | seems to be very steady rises with this one , bit of speculation prechristmas about the predator becoming the prey, putting all that together , possible corporate activity ?? | scrapman | |
21/12/2006 10:12 | cat if an offer comes in it will not be less than the price now,(530) and could be 10/20% more (50/100 points more) I am keeping a close eye on it and will only sell if it is stated that no offer is to be made. | omega1525 | |
21/12/2006 08:42 | Does that mean you are in 64k profit? :-) | rafieh | |
21/12/2006 08:25 | Well I'm in profit here . Should I cash in or wait. that's the 64k question. | cat100 | |
19/12/2006 11:52 | May be joining you in this one. Views in light of yesterday's news? Anyone suggest a buy-in price here - watching it slide a bit today | 2gemini | |
15/12/2006 10:26 | *Rumours that Smith & Nephew is looking to raise up to £1.5-billion to help finance its expected acquisition of Biomet (NASDAQ: BMET). - Looks like a discounted rights issue is going to get tabled. Normally this a minimum of 20% off. | liquidkid | |
15/12/2006 10:26 | *Rumours that Smith & Nephew is looking to raise up to £1.5-billion to help finance its expected acquisition of Biomet (NASDAQ: BMET). - Looks like a discounted rights issue is going to get tabled. Normally this a minimum of 20% off. | liquidkid |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions